全球超級崩散劑市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，超級崩散劑市場規模將從 2025 年的 5.3376 億美元成長至 10.511 億美元，2026 年至 2034 年的複合年成長率為 7.82%。

受市場超級崩散劑市場正經歷穩定成長。超級崩散劑是片劑的關鍵成分，它能使藥物在給藥後迅速崩壞，從而提高藥物吸收率和患者用藥依從性。口溶錠，尤其是在兒童和老年人群體中，也促進了市場的擴張。

主要成長要素包括製藥業的擴張和需要長期用藥的慢性病患者數量的增加。製藥公司正致力於開發改進的藥物遞送系統，以提高生物利用度和患者用藥便利性。製劑技術的進步也提高了超級崩散劑的性能和療效。新製劑獲得監管部門核准也促進了市場發展。

展望未來，藥物遞送技術的持續創新預計將推動市場成長。對學名藥和經濟型製劑的需求不斷成長，將創造更多機會。新興市場醫療保健覆蓋範圍的擴大預計也將做出顯著貢獻。總體而言，超級崩散劑將繼續在全球口服藥物遞送系統的改進中發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球超級崩散劑市場：依產品分類

• 市場分析、洞察與預測
• 改性澱粉
• 改性纖維素
• 交聯聚維酮
• 離子交換樹脂

第5章：全球超級崩散劑市場：以劑型分類

• 市場分析、洞察與預測
• 藥片
• 膠囊

第6章：全球超級崩散劑市場：依治療領域分類

• 市場分析、洞察與預測
• 消化系統疾病
• 神經系統疾病
• 腫瘤疾病
• 感染疾病
• 心血管疾病
• 血液疾病
• 發炎性疾病

第7章 全球超級崩散劑市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • BASF
  • Ashland Global
  • Dow DuPont
  • Roquette Freres
  • DFE Pharma
  • JRS PHARMA
  • Asahi Kasei
  • Merck
  • Corel Pharma Chem
  • Avantor Performance

The Superdisintegrants Market size is expected to reach USD 1051.10 Million in 2034 from USD 533.76 Million (2025) growing at a CAGR of 7.82% during 2026-2034.

The Global Superdisintegrants Market is witnessing steady growth due to the increasing demand for fast-dissolving oral dosage forms. Superdisintegrants are key ingredients in tablets that enable rapid breakdown after ingestion, improving drug absorption and patient compliance. The rising use of orally disintegrating tablets, particularly among pediatric and geriatric populations, is supporting market expansion.

Key drivers include growth in the pharmaceutical industry and the increasing prevalence of chronic diseases requiring long-term medication. Pharmaceutical manufacturers are focusing on developing improved drug delivery systems that enhance bioavailability and patient convenience. Technological advancements in formulation techniques are also boosting the performance and effectiveness of superdisintegrants. Regulatory approvals for new formulations further contribute to market development.

Looking ahead, the market is expected to grow with ongoing innovation in drug delivery technologies. The rising demand for generic drugs and cost-effective formulations will create additional opportunities. Emerging markets are likely to contribute significantly as healthcare access expands. Overall, superdisintegrants will continue to play a crucial role in improving oral drug delivery systems globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Modified Starch
• Modified Cellulose
• Crospovidone
• Ion Exchange Resin

By Formulation

• Tablets
• Capsules

By Therapeutic Area

• Gastrointestinal Diseases
• Neurological Diseases
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Hematological Diseases
• Inflammatory Diseases

COMPANIES PROFILED

• BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma Chem, Avantor Performance
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SUPERDISINTEGRANTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Modified Starch Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Modified Cellulose Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Crospovidone Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Ion Exchange Resin Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SUPERDISINTEGRANTS MARKET: BY FORMULATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Formulation
• 5.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Capsules Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SUPERDISINTEGRANTS MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Gastrointestinal Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurological Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Hematological Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Inflammatory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SUPERDISINTEGRANTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Formulation
  • 7.2.3 By Therapeutic Area
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Formulation
  • 7.3.3 By Therapeutic Area
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Formulation
  • 7.4.3 By Therapeutic Area
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Formulation
  • 7.5.3 By Therapeutic Area
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Formulation
  • 7.6.3 By Therapeutic Area
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SUPERDISINTEGRANTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BASF
  • 9.2.2 Ashland Global
  • 9.2.3 Dow DuPont
  • 9.2.4 Roquette Freres
  • 9.2.5 DFE Pharma
  • 9.2.6 JRS PHARMA
  • 9.2.7 Asahi Kasei
  • 9.2.8 Merck
  • 9.2.9 Corel Pharma Chem
  • 9.2.10 Avantor Performance